- Coordinator
- Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV, Germany
- Runs
- 1 January 2024 to 30 June 2025
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101138779
What the project is doing
In the project's own words, from its summary on CORDIS.
Dysregulation of lipid transport and metabolism is at the center of many diseases. Despite its crucial role, gaining a full understanding of lipid transport remains challenging as visualizing lipids and their transport by microscopy is almost impossible. By providing technological solutions to this problem, we envision to enable new therapeutic strategies with the corresponding benefits for society at large. A better understanding of lipid transport can help guide the design of drugs to for example treat fatty liver disease, which is estimated to affect up to quarter of the global population.
During the ERC PoC grant period, we plan to translate our current protocols to high throughput screening setups with the goal to service the pharmaceutical industry and design ready-to-use kits and devices that will allow academic laboratories to answer their unique research questions.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI